Results 241 to 250 of about 120,317 (381)
Abstract Lennox–Gastaut syndrome (LGS) is one of the most severe, yet one of the most discussed, childhood‐onset developmental and epileptic encephalopathies (DEEs). Dissent among epileptologists on the definition and minimum set of electroclinical features derives from the high etiological heterogeneity within the syndrome, which could make its ...
Antonella Riva +40 more
wiley +1 more source
Degradation of Typical PPCPs During Anaerobic Digestion and in Soil. [PDF]
Guo M, Xu L, Guo L, Hu J, Liu R.
europepmc +1 more source
A randomized, double‐blind, placebo‐controlled, multicenter study to evaluate the efficacy and safety of adjunctive cenobamate in Asian patients with focal seizures. Abstract Objectives This randomized, double‐blind, placebo‐controlled study (NCT04557085), conducted in China, Japan, and the Republic of Korea, evaluated the efficacy and safety of ...
Sang Kun Lee +20 more
wiley +1 more source
A comparative study on the efficacy of different combinational anti-seizure medication therapies following valproate monotherapy failure. [PDF]
Yan R +9 more
europepmc +1 more source
Epilepsy in dentatorubral–pallidoluysian atrophy: A systematic review and meta‐analysis
Summary of key clinical and electrophysiological characteristics of DRPLA‐related epilepsy from a systematic review and meta‐analysis of 1,191 patients. DRPLA patients with epilepsy showed earlier disease onset, longer CAG repeat expansion, and a tendency toward paternal inheritance. EEG findings frequently included photoparoxysmal responses.
Toru Horinouchi +10 more
wiley +1 more source
Managing epilepsy in older adults: A Saudi Arabian perspective on drug selection. [PDF]
Basheikh MA.
europepmc +1 more source
Anti‐seizure medications in patients with post‐stroke epilepsy: A survival analysis study
Abstract Objective The role of antiseizure medications (ASMs) in patients with post‐stroke epilepsy (PSE) is still debated. Although a few studies have compared the efficacy of different ASMs on mortality in patients with PSE, overall evidence on the impact of ASM use on survival is limited.
Ippazio Cosimo Antonazzo +9 more
wiley +1 more source
Cost-effectiveness analysis of pharmacogenetic-guided antiseizure medication therapy based on the risk of HLA-A*31:01 allele variants in Japan. [PDF]
Maruyama Y +5 more
europepmc +1 more source

